Background: Due to the physiological changes in the body during pregnancy, the increased susceptibility to viral infections during this period and also the high prevalence of coronavirus disease 2019 (COVID-19) in the Guilan province, Iran, this study aimed to evaluate risk factors, clinical symptoms, laboratory findings and imaging of pregnant mothers with COVID-19. Methods: In this descriptive study, 70 pregnant women aged 17–41 years with COVID-19 who were hospitalized from early March to late April 2020 were enrolled. Sampling was performed by census and from all hospitals in Guilan. The research instruments included a researcher-made questionnaire, including demographic characteristics, clinical symptoms, medical examinations, and paraclinical results. Data were analyzed with SPSS version 16. Frequency and percent were used to describe qualitative variables; for quantitative variables, if they were normally distributed, mean and standard deviation were used, and if they were non-normal, median and interquartile range (IQR) were used. Results: The most severe symptoms recorded in mothers at the time of hospitalization were fever (47%), shortness of breath (16%) and cough (15%), respectively. One of 68 (1%) was in the severe stage of the disease and two mothers (2%) were in critical condition and admitted to the intensive care unit and finally died. Fifty-five of 66 women (83%) had lymphopenia, 22 of 42 (52%) tested positive on PCR, and 30 of 33 (90%) had an increase in lactate dehydrogenase (LDH) levels.Results showed that 15 of 32 patients who gave birth had preterm delivery (46%). Conclusion: The most common manifestations of the disease in pregnant women were fever, cough and shortness of breath, and in some cases muscle pain. The most common laboratory finding in infected mothers was lymphopenia. Complications of pregnancy and childbirth in women included an increase in cesarean delivery.
Background and aims: Despite the availability of vaccines, antibiotics, and healthcare services, meningitis is a serious cause of morbidity and mortality worldwide. Thus, this study investigated the incidence of meningitis and identified areas with the highest incidence in Guilan. Methods: This study calculated the cumulative incidence of meningitis (confirmed and probable cases) and fever and neurological symptoms syndrome per 100,000 population each year. Join point regression analysis was used to identify noticeable changes in the trend of disease, and ArcGIS software was employed to determine high-risk areas. Results: Overall, 653 cases of syndrome were reported during 2011-22, of whom 404 (61.87%) were confirmed and probable cases of meningitis. The age of 148 (36.63%) meningitis patients was less than 5 years, and 255 (63.12%) were male. The outcome of death was reported in 11.54% of confirmed cases and 6.28% of all cases. Joinpoint regression analysis revealed significant decreasing trends in the incidence of fever and neurological symptoms post-2018 across all age groups (APC: -37.45%, P<0.05), with a notable decrease in children<5 (APC: -54.03%, P<0.05). Additionally, a significant reduction was found in those over 5 years after 2015. For meningitis cases across all ages and children under 5, non-significant trends included a breakpoint in 2019, with a subsequent decline. Meningitis incidence demonstrated a nonsignificant decreasing trend among individuals over 5 years throughout 2011-2022. Conclusion: The annual incidence of meningitis and syndrome in Guilan was lower than the average in the whole country, but the case fatality rate was higher.